Detailed answers about ANTIGENESIS BIOLOGICS LTD, including incorporation, status, business activity, and accounts information.
When was ANTIGENESIS BIOLOGICS LTD founded?
ANTIGENESIS BIOLOGICS LTD was officially incorporated on 1 February 2024 and is registered under company number NI709560. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ANTIGENESIS BIOLOGICS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ANTIGENESIS BIOLOGICS LTD?
ANTIGENESIS BIOLOGICS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ANTIGENESIS BIOLOGICS LTD do?
ANTIGENESIS BIOLOGICS LTD operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is ANTIGENESIS BIOLOGICS LTD's registered address?
The registered office address of ANTIGENESIS BIOLOGICS LTD is 78 TECONNAUGHT ROAD, CROSSGAR, DOWNPATRICK, NORTHERN IRELAND, BT30 9HH. This is the official address filed with Companies House for legal and statutory correspondence.
Is ANTIGENESIS BIOLOGICS LTD financially stable?
The most recent accounts for ANTIGENESIS BIOLOGICS LTD were made up to 28 February 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 30 November 2026.
Has ANTIGENESIS BIOLOGICS LTD changed its name?
Yes, ANTIGENESIS BIOLOGICS LTD has had 3 previous names: XAPHE LTD (changed 23 October 2024), ANTIGENESIS BIOLOGICS LTD (changed 16 October 2024), ANTIGENEIS BIOLOGICS LTD (changed 5 February 2024).